Your browser version may not work well with NCBI's Web applications. More information here...
1: Nat Neurosci. 2008 Nov;11(11):1302-10. Epub 2008 Oct 5.
Related Articles, Links
Click here to read Click here to read Click here to read
Palmitoylation-dependent neurodevelopmental deficits in a mouse model of 22q11 microdeletion.

Mukai J, Dhilla A, Drew LJ, Stark KL, Cao L, MacDermott AB, Karayiorgou M, Gogos JA.

Department of Physiology and Cellular Biophysics, Columbia University, New York, New York 10032, USA.

Individuals with 22q11.2 microdeletions have cognitive deficits and a high risk of developing schizophrenia. Here we provide evidence that primary hippocampal neurons from a mouse model of 22q11.2 deletion (Df(16)A(+/-) mice) have decreased density of dendritic spines and glutamatergic synapses, as well as impaired dendritic growth. These deficits were prevented by introduction of the enzymatically active ZDHHC8 palmitoyltransferase encoded by a gene in the 22q11.2 locus, and they were also observed in primary cultures from Zdhhc8-deficient mice. Many of these deficits were also present in the hippocampi of adult Df(16)A(+/-) and Zdhhc8-deficient mice. Finally, we provide evidence that PSD95 is one of the substrates of ZDHHC8. Our analysis reveals that 22q11.2 microdeletion results in deficits in neuronal development and suggests that impaired neuronal protein palmitoylation contributes to many of these deficits.

Publication Types:
PMID: 18836441 [PubMed - indexed for MEDLINE]